FDA lists 20 drugs under review for safety risks

09/7/2008 | Wall Street Journal, The

The FDA released a list of 20 medicines being investigated for potential adverse effects to provide early warnings to consumers and health care professionals. The list includes Eli Lilly and Co.'s Cymbalta, an antidepressant, and Purdue Pharma's OxyContin, a pain medication. Companies expressed support for the agency's drug-safety efforts, but some are concerned that data presented to patients lack context and may affect the course of their treatment.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR